Arix Bioscience Plc (ARIX) Cotización

1-03 B DELL $100.24

A nice clarification of my stance, from the Tullow Oil board:
https://www.lse.co.uk/profiles/antonvb/
Second post:
Here's a question for you xxnjr. You appear to be more knowledgeable than most on here regarding the workings of Tullow and the O&G industry. So the question is w

Excited to see if they announce any news with Winner Medical this quarter or if they wait for a big PR bomb on this.

Agreed LFG GVSI !!!!!!!!$$$$$$$$$$

Katzaroff will lose a lot of money if he will take this shell to expert market.. is he such stupid ? I believe yes.. the most supid ceo i"ve ever seen...but hey.. he qon't lose his money.. only the one he stolen from investors and their families...

I guess the only question is I wonder if these posters are Diversified enough??


I know most Traders nowadays are including myself.

Surely they have their own investments to worry or follow other than a stock which they have no Financial interesting.

Report 7.1 SPX Cycles Long Range Projection Chart. Today the Weekly opened in an UNCONFIRMED W-S-1. For the W-S-1 to get confirmed, the SPX must remain below the Weekly UTL (currently at 6030.68) until the close on Friday. If the W-S-1 gets confirmed the projected low will be 5781.96, the low will

RNVA key word """GUESS""" would love more than anything for some one to produce a legit, legal filing, or docket that says RNVA still in buisness ,,,good luck.

emmm the way I feel about it there won't be a next time :+)

Next Leg Up coming !!!!!!$$$$$$$$ DBMM

Bashers out in full force on here and X, wasting tons of time as usual. Must be something huge in the pipeline for bulls.

You should just put the wall up.   Lol.   

Report 7.1 SPX Cycles Long Range Projection Chart. Today the Weekly opened in an UNCONFIRMED W-S-1. For the W-S-1 to get confirmed, the SPX must remain below the Weekly UTL (currently at 6030.68) until the close on Friday. If the W-S-1 gets confirmed the projected low will be 5781.96, the low will

Probably more likely to see a dragon fly over being ridden on by a Sasquatch, but there's always a chance. 😆

I think that Li was either misinformed or ducking your question. Generally, one of the rights an exclusive licensee has is the right to enforce its exclusivity against third parties. The exclusive license is worthless if only the licensor can enforce it but chooses not to do so. Unless there are

No addresses for Bloxcross or management other than a mail drop with their Registered Agent in Delaware. That means they don't want to be found much less held accountable.

They tried and failed to register trademarks. The addresses to those were an apartment in San Marcos, CA...rough

Highland Opportunities and Income Fund (HFRO) Announces Commencement of Tender and Exchange Offer (2/03/25)

DALLAS, Feb. 3, 2025 /PRNewswire/ -- The Highland Opportunities and Income Fund (NYSE: HFRO) ("HFRO" or the "Fund") today announced the commencement of a tender and exchange off

Here's a recently posted detailed review of the EXIM process on Reddit. Poster claims to have met personally with senior EXIM staff. Also mentions NioCorp as an example of a company going through the process. Haven't seen this posted anywhere else. Lengthy but worth a look.

https:

https://x.com/RapidResponse47/status/1886515818264973705

It's www.INCMWweTRUST.org

https://timestabloid.com/why-holding-1000-to-5000-xrp-could-be-a-game-changer/

Announcement of Receipt of Quarterly Royalty Report and Royalty Payment (2/03/25)

On January 30, 2025, Mesabi Trust received the quarterly royalty report of iron ore production and shipments out of Silver Bay, Minnesota during the quarter ended December 31, 2024 (the “Royalty Report”)

Clinical trials in India are for the treatment of cancer of the lymph nodes. But then you already know that. Swing and a miss.

The Bangles - Manic Monday
https://www.youtube.com/watch?v=SsmVgoXDq2w

VIRX: Delisted from the Nasdaq to the OTC. ***pps dropped 55% from ~.15 to .678 on 9+ million volume.

https://otce.finra.org/otce/dailyList?viewType=Additions